Home/Filings/4/0001493152-23-007604
4//SEC Filing

Al-Siddiq Waqaas 4

Accession 0001493152-23-007604

CIK 0001630113other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:26 PM ET

Size

10.1 KB

Accession

0001493152-23-007604

Insider Transaction Report

Form 4
Period: 2023-03-12
Al-Siddiq Waqaas
DirectorCEO and Chairman of the Board10% Owner
Transactions
  • Award

    Option (right to purchase)

    2023-03-12+350,0003,549,984 total
    Exercise: $1.25Exp: 2033-01-27Common Stock (350,000 underlying)
  • Award

    Option (right to purchase)

    2023-03-12+350,0003,899,984 total
    Exercise: $1.75Exp: 2033-01-27Common Stock (350,000 underlying)
  • Award

    Option (right to purchase)

    2023-03-12+1,000,0004,899,984 total
    Exercise: $0.81Exp: 2033-01-27Common Stock (1,000,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to the 2016 Equity Incentive Plan, with 175,000 of the Option vested January 27, 2023, and the remaining unvested Option of 175,000 will vest on January 27, 2024.
  • [F2]Granted pursuant to the 2016 Equity Incentive Plan, with 250,000 of the Option vested January 27, 2023, and the remaining unvested Option of 20,833 will become vested and exercisable every month thereafter starting on February 27, 2023, until the Option is 100% vested.

Documents

1 file

Issuer

BIOTRICITY INC.

CIK 0001630113

Entity typeother

Related Parties

1
  • filerCIK 0001783199

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:26 PM ET
Size
10.1 KB